Skip to content

APOTHEEK SCHEPENS: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK SCHEPENS

BE 0771.512.462
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€44,892
2024 · €52,032-€7,140
Equity
€49,891
2024 · €137,996-€88,105
Cash
€33,060
2024 · €19,289+€13,771
Balance sheet total
€448,518
2024 · €491,341-€42,824

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets -€30,730

    down €30,730 (-15.4%), from €199,809 to €169,079

    of which Plant, machinery and equipment: -€29,908

  • Receivables within one year -€29,050

    down €29,050 (-18.3%), from €158,448 to €129,399

    of which Other amounts receivable: -€63,257

  • Cash +€13,771

    up €13,771 (+71.4%), from €19,289 to €33,060

    mainly Other debts (+€56,255) and Net result for the year (+€44,892)

  • Stocks and contracts +€6,295

    up €6,295 (+6.7%), from €93,907 to €100,203

Equity and liabilities
  • Reserves -€88,105

    down €88,105 (-66.2%), from €132,997 to €44,892

  • Other debts +€56,255

    new in 2025: €56,255

  • Debts after one year -€41,391

    down €41,391 (-29.6%), from €139,755 to €98,364

  • Accrued charges and deferred income +€18,321

    up €18,321 (+333%), from €5,504 to €23,825

  • Trade debts +€15,322

    up €15,322 (+23.4%), from €65,519 to €80,841

Income statement
  • Gross operating margin -€6,269

    down €6,269 (-3.1%), from €200,858 to €194,590

  • Financial charges -€5,806

    down €5,806 (-34.9%), from €16,640 to €10,835

  • Staff costs +€5,041

    up €5,041 (+6.0%), from €84,470 to €89,511

  • Financial income -€4,211

    down €4,211 (-98.0%), from €4,296 to €85

  • Taxes -€3,013

    down €3,013 (-19.4%), from €15,531 to €12,518

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €52,032
Gross operating margin -€6,269
Staff costs -€5,041
Depreciation -€133
Other operating charges -€305
Financial income -€4,211
Financial charges +€5,806
Taxes +€3,013
Result 2025 €44,892
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€195,651
Investment €0
Financing -€181,880
Cash 2024 €19,289
Net result for the year +€44,892
Depreciation +€34,030
Stocks and contracts -€6,295
Receivables within one year +€29,050
Deferred charges and accrued income -€190
Trade debts +€15,322
Tax, wage and social debts +€4,267
Other debts +€56,255
Accrued charges and deferred income +€18,321
Debts after one year -€41,391
Current portion of long-term debt -€7,493
Contributions, distributions and other -€132,997
Cash 2025 €33,060
brings cash intakes cash out
Every line side by side 45 lines
Line Code 2024 2025 Change %
Total assets 20/58 €491,341 €448,518 -€42,824 -8.7%
Fixed assets 21/28 €204,760 €170,730 -€34,030 -16.6%
Intangible fixed assets 21 €4,951 €1,651 -€3,300 -66.7%
Tangible fixed assets 22/27 €199,809 €169,079 -€30,730 -15.4%
Plant, machinery and equipment 23 €197,740 €167,832 -€29,908 -15.1%
Furniture and vehicles 24 €2,069 €1,247 -€822 -39.7%
Current assets 29/58 €286,581 €277,787 -€8,794 -3.1%
Stocks and contracts in progress 3 €93,907 €100,203 +€6,295 +6.7%
Stocks 30/36 €93,907 €100,203 +€6,295 +6.7%
Amounts receivable within one year 40/41 €158,448 €129,399 -€29,050 -18.3%
Trade receivables 40 €91,777 €125,984 +€34,208 +37.3%
Other amounts receivable 41 €66,672 €3,414 -€63,257 -94.9%
Cash at bank and in hand 54/58 €19,289 €33,060 +€13,771 +71.4%
Deferred charges and accrued income 490/1 €14,937 €15,126 +€190 +1.3%
Total equity and liabilities 10/49 €491,341 €448,518 -€42,824 -8.7%
Equity 10/15 €137,996 €49,891 -€88,105 -63.8%
Contributions 10/11 €4,999 €4,999 = 0.0%
Reserves 13 €132,997 €44,892 -€88,105 -66.2%
Distributable reserves 133 €132,997 €44,892 -€88,105 -66.2%
Profit (loss) carried forward 14 - €0 =
Amounts payable 17/49 €353,346 €398,627 +€45,281 +12.8%
Amounts payable after more than one year 17 €139,755 €98,364 -€41,391 -29.6%
Financial debts 170/4 €139,755 €98,364 -€41,391 -29.6%
Amounts payable within one year 42/48 €208,087 €276,438 +€68,351 +32.8%
Current portion of amounts payable after more than one year 42 €123,164 €115,671 -€7,493 -6.1%
Trade debts 44 €65,519 €80,841 +€15,322 +23.4%
Suppliers 440/4 €65,519 €80,841 +€15,322 +23.4%
Taxes, remuneration and social security 45 €19,404 €23,672 +€4,267 +22.0%
Taxes 450/3 €8,486 €12,573 +€4,087 +48.2%
Remuneration and social security 454/9 €10,919 €11,098 +€180 +1.6%
Other amounts payable 47/48 - €56,255 +€56,255
Accrued charges and deferred income 492/3 €5,504 €23,825 +€18,321 +333%
Remuneration, social security and pensions 62 €84,470 €89,511 +€5,041 +6.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €33,897 €34,030 +€133 +0.4%
Other operating charges 640/8 €2,584 €2,889 +€305 +11.8%
Gross operating margin 9900 €200,858 €194,590 -€6,269 -3.1%
Operating profit (loss) 9901 €79,907 €68,160 -€11,747 -14.7%
Financial income 75/76B €4,296 €85 -€4,211 -98.0%
Recurring financial income 75 €4,296 €85 -€4,211 -98.0%
Financial charges 65/66B €16,640 €10,835 -€5,806 -34.9%
Recurring financial charges 65 €16,640 €10,835 -€5,806 -34.9%
Profit (loss) for the period before taxes 9903 €67,563 €57,410 -€10,153 -15.0%
Income taxes 67/77 €15,531 €12,518 -€3,013 -19.4%
Profit (loss) for the period 9904 €52,032 €44,892 -€7,140 -13.7%
Profit (loss) for the period to be appropriated 9905 €52,032 €44,892 -€7,140 -13.7%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 15 October 2026 via checked.be.